United States Biotechnology & Medical Research

NovaBay Pharmaceuticals Inc (NBY)

Track

Over the past 90 days, NovaBay Pharmaceuticals Inc. recorded three insider transactions, all of which were sales totaling approximately $80,834. These sales were executed by the CEO and associated entities on June 15, 2026. This activity follows a period of stock price volatility and a recent earnings report that missed expectations.
Ticker: NBY Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for NovaBay Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 15 Jun 2026
Value US$108,437.20 | Price 160.78 | Shares 58,210 (-4.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-15 S Sale
Kazley Michael John

Chief Executive Officer

Executive Director Large shareholder
58,210 -4.5%
160.78
US$108,437 		58,210 -4.5% 160.78 US$108,437
2026-06-17 2026-06-15 S Sale
1.7
Framework Ventures IV L.P.
Large shareholder
12,958 -37.6%
307.70
US$1,542,304 		12,958 -37.6% 307.70 US$1,542,304
2026-06-17 2026-06-15 S Sale
R01 Fund LP

Chief Executive Officer

Executive Director Large shareholder
97,387 -12.8%
351.95
US$2,435,846 		97,387 -12.8% 351.95 US$2,435,846
2025-04-15 2025-04-08 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
300 +0.0%
0.47
US$140 		300 +0.0% 0.47 US$140
2025-04-15 2025-04-04 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
4,538 +0.4%
0.52
US$2,367 		4,538 +0.4% 0.52 US$2,367
2025-04-15 2025-04-03 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
22,976 +2.3%
0.56
US$12,929 		22,976 +2.3% 0.56 US$12,929
2025-04-15 2025-04-02 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
917 +0.1%
0.58
US$532 		917 +0.1% 0.58 US$532
2025-04-15 2025-04-01 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
19,915 +2.0%
0.59
US$11,650 		19,915 +2.0% 0.59 US$11,650
2025-04-15 2025-03-31 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
21,654 +2.3%
0.59
US$12,776 		21,654 +2.3% 0.59 US$12,776
2025-04-15 2025-03-28 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
49,400 +5.5%
0.61
US$30,253 		49,400 +5.5% 0.61 US$30,253
2025-04-15 2025-03-27 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
600 +0.1%
0.61
US$365 		600 +0.1% 0.61 US$365
2025-04-15 2025-03-27 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
18,504 +2.1%
0.62
US$11,380 		18,504 +2.1% 0.62 US$11,380
2025-04-15 2025-03-26 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
13,292 +1.5%
0.61
US$8,095 		13,292 +1.5% 0.61 US$8,095
2025-04-15 2025-03-25 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
22,635 +2.7%
0.61
US$13,807 		22,635 +2.7% 0.61 US$13,807
2025-04-15 2025-03-24 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
100 +0.0%
0.61
US$60 		100 +0.0% 0.61 US$60
2025-04-15 2025-03-21 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
6,372 +0.8%
0.61
US$3,855 		6,372 +0.8% 0.61 US$3,855
2025-04-15 2025-03-20 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
5,320 +0.6%
0.61
US$3,271 		5,320 +0.6% 0.61 US$3,271
2025-04-15 2025-03-19 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
1,500 +0.2%
0.60
US$904 		1,500 +0.2% 0.60 US$904
2025-04-15 2025-03-18 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
14,000 +1.7%
0.63
US$8,820 		14,000 +1.7% 0.63 US$8,820
2025-04-15 2025-03-18 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
10,000 +1.2%
0.63
US$6,300 		10,000 +1.2% 0.63 US$6,300
2025-04-15 2025-03-14 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
25,511 +3.3%
0.63
US$16,072 		25,511 +3.3% 0.63 US$16,072
2025-04-15 2025-03-13 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
34 +0.0%
0.64
US$22 		34 +0.0% 0.64 US$22
2025-04-15 2025-03-12 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
11,837 +1.5%
0.62
US$7,370 		11,837 +1.5% 0.62 US$7,370
2025-04-15 2025-03-11 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
2,148 +0.3%
0.58
US$1,246 		2,148 +0.3% 0.58 US$1,246
2025-04-15 2025-03-10 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
14,645 +1.9%
0.58
US$8,494 		14,645 +1.9% 0.58 US$8,494
2025-04-15 2025-03-07 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
102 +0.0%
0.55
US$56 		102 +0.0% 0.55 US$56
2025-04-15 2025-03-04 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
4,000 +0.5%
0.58
US$2,314 		4,000 +0.5% 0.58 US$2,314
2025-04-15 2025-02-28 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
13,108 +1.8%
0.60
US$7,891 		13,108 +1.8% 0.60 US$7,891
2025-04-15 2025-02-27 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
385 +0.1%
0.61
US$235 		385 +0.1% 0.61 US$235
2025-04-15 2025-02-26 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
6,302 +0.9%
0.61
US$3,844 		6,302 +0.9% 0.61 US$3,844
2025-04-15 2025-02-25 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
25,033 +3.5%
0.62
US$15,518 		25,033 +3.5% 0.62 US$15,518
2025-04-15 2025-02-24 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
450 +0.1%
0.62
US$279 		450 +0.1% 0.62 US$279
2025-04-15 2025-02-20 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
1,836 +0.3%
0.63
US$1,157 		1,836 +0.3% 0.63 US$1,157
2025-04-15 2025-02-19 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
49,664 +7.6%
0.67
US$33,349 		49,664 +7.6% 0.67 US$33,349
2025-04-15 2025-02-18 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
3,222 +0.5%
0.66
US$2,127 		3,222 +0.5% 0.66 US$2,127
2025-04-15 2025-02-04 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
26,718 +4.3%
0.64
US$16,966 		26,718 +4.3% 0.64 US$16,966
2025-04-15 2025-02-03 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
2,597 +0.4%
0.64
US$1,649 		2,597 +0.4% 0.64 US$1,649
2025-04-15 2025-01-31 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
70,685 +12.9%
0.65
US$45,825 		70,685 +12.9% 0.65 US$45,825
2025-04-15 2025-01-27 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
31,703 +6.1%
0.69
US$21,875 		31,703 +6.1% 0.69 US$21,875
2022-12-07 2022-12-06 S Sale
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
1
1.81
US$2 		1 1.81 US$2
2022-12-07 2022-12-06 S Sale
1.8
Kunin Audrey

Chief Product Officer

Officer
1
1.81
US$2 		1 1.81 US$2
2022-11-23 2022-11-21 S Sale
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
5,960 -100.0%
2.10
US$12,545 		5,960 -100.0% 2.10 US$12,545
2022-11-23 2022-11-21 S Sale
1.8
Kunin Audrey

Chief Product Officer

Executive Director
5,960 -100.0%
2.10
US$12,545 		5,960 -100.0% 2.10 US$12,545
2022-09-16 2022-09-14 B Purchase
1.1
Hall Justin

CEO, GC and Director

Executive Director
10,000 +13.7%
0.15
US$1,500 		10,000 +13.7% 0.15 US$1,500
2022-09-16 2022-09-14 S Sale
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
291,368 -58.3%
0.16
US$46,094 		291,368 -58.3% 0.16 US$46,094
2022-09-16 2022-09-14 S Sale
1.8
Kunin Audrey

Chief Product Officer

Executive Director
291,368 -58.3%
0.16
US$46,094 		291,368 -58.3% 0.16 US$46,094
2021-12-06 2021-12-06 B Purchase
1.1
Hall Justin

CEO, GC and Director

Executive Director
69,767 +2049.0%
0.43
US$30,000 		69,767 +2049.0% 0.43 US$30,000
2021-12-06 2021-12-06 B Purchase
0.9
Jones Andrew D.

CFO

Officer
36,765 +40.5%
0.44
US$16,177 		36,765 +40.5% 0.44 US$16,177
2021-12-07 2021-12-03 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
101,650 +25.5%
0.46
US$47,013 		101,650 +25.5% 0.46 US$47,013
2021-12-07 2021-12-03 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
101,650 +25.5%
0.46
US$47,013 		101,650 +25.5% 0.46 US$47,013
2021-12-06 2021-12-03 B Purchase
0.9
Jones Andrew D.

CFO

Officer
8,690 +10.6%
0.44
US$3,824 		8,690 +10.6% 0.44 US$3,824
2021-12-06 2021-12-02 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
262,369 +192.9%
0.48
US$124,888 		262,369 +192.9% 0.48 US$124,888
2021-12-06 2021-12-02 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
262,369 +192.9%
0.48
US$124,888 		262,369 +192.9% 0.48 US$124,888
2021-12-03 2021-12-01 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
14,848 +12.3%
0.49
US$7,276 		14,848 +12.3% 0.49 US$7,276
2021-12-03 2021-12-01 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
14,848 +12.3%
0.49
US$7,276 		14,848 +12.3% 0.49 US$7,276
2021-12-02 2021-11-30 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
30,000 +32.9%
0.46
US$13,800 		30,000 +32.9% 0.46 US$13,800
2021-12-02 2021-11-30 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
30,000 +32.9%
0.46
US$13,800 		30,000 +32.9% 0.46 US$13,800
2021-11-24 2021-11-23 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
66,133 +264.5%
0.46
US$30,368 		66,133 +264.5% 0.46 US$30,368
2021-11-24 2021-11-23 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
66,133 +264.5%
0.46
US$30,368 		66,133 +264.5% 0.46 US$30,368
2021-11-24 2021-11-22 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
25,000 +inf%
0.46
US$11,500 		25,000 +inf% 0.46 US$11,500
2021-11-24 2021-11-22 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
25,000 +inf%
0.46
US$11,500 		25,000 +inf% 0.46 US$11,500
2020-08-19 2020-08-17 S Sale
3.6
WU MIJIA
Non-Executive Director
20,000 -100.0%
1.35
US$27,000 		20,000 -100.0% 1.35 US$27,000
2020-08-04 2020-08-01 S Sale
3.9
Fu Jian Ping
Large shareholder
1,302,350 -24.6%
1.23
US$1,601,890 		1,302,350 -24.6% 1.23 US$1,601,890
2019-06-13 2019-06-11 S Sale
3.6
WU MIJIA
15,873 -100.0%
4.04
US$64,127 		15,873 -100.0% 4.04 US$64,127
2019-06-13 2019-06-11 S Sale
3.9
Fu Jian Ping
Large shareholder
380,954 -6.7%
3.84
US$1,462,863 		380,954 -6.7% 3.84 US$1,462,863
2019-06-13 2019-06-11 S Sale
3.4
Pioneer Pharma (Hong Kong) Co Ltd
Large shareholder
24,326 -0.5%
4.04
US$98,277 		24,326 -0.5% 4.04 US$98,277
2019-06-13 2019-06-10 S Sale
3.6
WU MIJIA
47,619 -100.0%
2.03
US$96,667 		47,619 -100.0% 2.03 US$96,667
2015-08-21 2015-08-20 B Purchase Najafi Ramin

Chief Executive Officer

Executive Director Large shareholder
6,000 +100.0%
0.44
US$2,640 		6,000 +100.0% 0.44 US$2,640
2015-08-21 2015-08-19 B Purchase Najafi Ramin

Chief Executive Officer

Executive Director Large shareholder
6,000 +inf%
0.50
US$3,000 		6,000 +inf% 0.50 US$3,000
2015-03-05 2015-03-03 B Purchase Najafi Ramin

Chief Executive Officer

Executive Director Large shareholder
166,666 +5.2%
0.60
US$100,000 		166,666 +5.2% 0.60 US$100,000
2015-03-05 2015-03-03 B Purchase Pioneer Pharma (Singapore) Pte. Ltd. Large shareholder
2,590,000 +37.0%
0.60
US$1,554,000 		2,590,000 +37.0% 0.60 US$1,554,000
2015-03-05 2015-03-03 B Purchase SIECZKAREK MARK M Non-Executive Director
166,666 +559.3%
0.60
US$100,000 		166,666 +559.3% 0.60 US$100,000
2014-12-16 2014-12-12 B Purchase Stroman David W.

SVP, Ophthalmic Product Devt.

Officer
10,000 +76.9%
0.66
US$6,600 		10,000 +76.9% 0.66 US$6,600
2014-12-15 2014-12-12 B Purchase PAULSON THOMAS J

CFO

Officer
10,000 +17.2%
0.68
US$6,800 		10,000 +17.2% 0.68 US$6,800
2014-12-15 2014-12-12 B Purchase Najafi Ramin

Chief Executive Officer

Executive Director Large shareholder
50,000
0.65
US$32,500 		50,000 0.65 US$32,500
Explore more

More insider trading research around NovaBay Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America